Got Disney said:
Dee,
have been using it for 8 years. It is also not banned you can buy it across the country in health food stores and you can purchase bandaids that have it on it. Has been recomended for my DH by his Dr. to use for his Hep C that has done wonders for that. All the info you hear on turning blue is from years nad years ago and has only happened to one woman. We even used it in the Hospital and that is where I first found out about it.
It is not illegal. Go look in your heath food store they sell it at a ridiculous price. Im not blue and take it every day. Have never been sick again since I started taking. Had chronic sinus infections and # of other problems. I have not had the fluin 8 years,or any kind of infection for that matter and I love it...Have turned on many people to it and they also have had gret luck with it and cant imagine being without it....But I can never give up a great argument...

Opinions is what makes the world go round...Great country America...
T99-39 Print Media: 301-827-6242
August 17, 1999
Consumer Inquiries: 888-INFO-FDA
FDA ISSUES FINAL RULE ON
OTC DRUG PRODUCTS CONTAINING COLLOIDAL SILVER
The FDA has issued a Final Rule declaring that all over- the-counter (OTC) drug products containing colloidal silver or silver salts are not recognized as safe and effective and are misbranded.
Colloidal silver is a suspension of silver particles in a colloidal (gelatinous) base. In recent years, colloidal silver preparations of unknown formulation have been appearing in stores. These products are labeled to treat adults and children for diseases including HIV, AIDS, cancer, tuberculosis, malaria, lupus, syphilis, scarlet fever, shingles, herpes, pneumonia, typhoid, tetanus and many others.
According to the Final Rule, a colloidal silver product for any drug use will first have to be approved by FDA under the new drug application procedures. The Final rule classifies colloidal silver products as misbranded because adequate directions cannot be written so that the general public can use these drugs safely for their intended purposes. They are also misbranded when their labeling falsely suggests that there is substantial scientific evidence to establish that the drugs are safe and effective for their intended uses.
The indiscriminate use of colloidal silver solutions has resulted in cases of argyria, a permanent blue-gray discoloration of the skin and deep tissues.
Colloidal silver ingredients and silver salts include silver proteins, mild silver protein, strong silver protein, silver chloride, and silver iodide. The dosage form of these colloidal silver products is usually oral, but product labeling also contains directions for topical and, occasionally, intravenous use.
In reaching its decision, FDA considered all of the information described in the proposed rule (October 15, 1996) and submitted by the public in response to that proposal, the Final Rule becomes effective on September 16, 1999, 30 days after publication.
Also, from the Federal Register:
Comments on Safety and Effectiveness
2. One comment expressed concern that many different silver
products being marketed are inferior products and are not even true
colloids. Another comment stated that the vast majority of silver
products being sold are fraudulent products. The comment noted that it
had tested a number of these products and found that several actually
had no silver content, one did not contain the silver particle size as
stated on the label, and only one product exceeded all stated purity
and stability claims found on the label. The comment added that many of
the products were only duplicates of older colloidal silver products.
The comment considered these ``newer'' products as having the same
dangers, intermittent effectiveness, and lack of stability as the older
products. The comment contended that the vast majority of the colloidal
silver products it tested are totally useless, some were dangerous to
ingest, and some were possibly a threat to life. The comment stated
that it is a major problem to keep off the market these so-called
``colloidal silver'' products that contain significant amounts of
silver ions and silver salts. The comment suggested a revision of the
United States Pharmacopeia (USP) specifications for these products.
Another comment stated that many of the colloidal silver products
it analyzed are considered ``Bredig Sols'' (simple colloidal silver),
referring to Bredig, Heidelberg, 1893. The comment added that a pure
Bredig Sol is simply elemental silver in distilled water, while some
Bredig Sols are mixed with saline to make them isotonic. The comment
mentioned that the silver content in these products (a viable product
could contain 0.005 percent silver) is many magnitudes less than the
silver content of the products discussed by FDA in its safety and
effectiveness evaluation (61 FR 53685 at 53686). The comment contended
that the agency had not reviewed the Bredig Sols and disagreed with the
agency's assumptions that there is an analogous comparison between
colloidal silver proteins and other silver compounds to a simple Bredig
Sol.
[[Page 44655]]
These comments highlight the existing problems in trying to
establish whether any silver salts or colloidal silver ingredients can
be generally recognized as safe and effective. Because of the
acknowledged differences in silver content and particle size of the
silver in various products, it is difficult to draw conclusions from
clinical studies conducted on different silver products. The agency has
minimal manufacturing controls information on these products. The
agency does not have information that assures the strength, quality,
purity, and potency of various silver products used in clinical studies
and other reports included in the comments.
Concerning the comment suggesting a revision of USP specifications,
the proposed rule stated that none of the formerly recognized colloidal
silver preparations (e.g., colloidal silver iodide, strong (or mild)
silver protein, ammoniacal silver nitrate solution) has been official
in the USP or the National Formulary (N.F.) since 1975. It is
industry's responsibility to have these silver ingredients reinstated
in the USP or N.F. and to revise the specifications used in the former
compendial monographs. Concerning ``Bredig Sols,'' the comment did not
provide any specific safety and effectiveness data; thus, the agency is
not able to establish that such products are generally recognized as
safe and effective.
The register also lists studies of effectuveness. And there have been more than than 1 case of argyria documented.